Benatti Luca

EDGAR CIK 0001613842

Quince Therapeutics, Inc. - QNCX

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
1
($173,500)
-50,000 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
12/26/2025
12/29/2025
Sell
-50,000 @ $3.47
 ($173,500) 39,179 (-56.07%) Direct